BIOTECH STOCK INVESTING

Covering Biotech Stocks In The Following Areas'Drug Stocks' Gene Therapy' Stem Cells' DNA' Bio Metrics' Antibiotics' Vaccines' Cancer Drugs' Immune Therapy Drugs. Genetic Diseases' Nutrition Products. Nutraceuticals'. Some Of The Companies Covered Celgene'Gilead'Biogen'Vertex'Amgen'Abbvie'Regeneron'Alexion'Exelixis'Viking Therapeutics'Sarepta'Therapeutics'Sage Therapeutics'Incyte Corporation'Sparks Therapeutics'Puma Biotechnology'Neurocrine Bioscience'Astrazeneca'Celldex Therapeutics''

Thursday, August 29, 2019

U.S. Cannabis Market Is Booming, Curaleaf Chairman Says

Posted by jim moylan at 12:34 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Thursday, August 22, 2019

Tilray CEO Sees Canada Profit in the 'Next Quarter or Two'

Posted by jim moylan at 1:02 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Wednesday, August 14, 2019

Cannabis company Tilray beats revenue expectations but reports adjusted ...

Posted by jim moylan at 1:28 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Comments (Atom)

Search This Blog

Followers

About Me

jim moylan
View my complete profile

Blog Archive

  • ▼  2019 (39)
    • ▼  August (3)
      • U.S. Cannabis Market Is Booming, Curaleaf Chairman...
      • Tilray CEO Sees Canada Profit in the 'Next Quarter...
      • Cannabis company Tilray beats revenue expectations...
    • ►  April (1)
    • ►  March (35)

Biotech Stock Investing

Simple theme. Powered by Blogger.